<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">        <PMID Version="1">30097231</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>26</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>04</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1879-0461</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>129</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                    </PubDate>                </JournalIssue>                <Title>Critical reviews in oncology/hematology</Title>                <ISOAbbreviation>Crit. Rev. Oncol. Hematol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Ionizing radiation-induced cellular senescence promotes tissue fibrosis after radiotherapy. A review.</ArticleTitle>            <Pagination>                <MedlinePgn>13-26</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S1040-8428(18)30085-4</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.critrevonc.2018.06.012</ELocationID>            <Abstract>                <AbstractText>Ionizing radiation-exposure induces a variety of cellular reactions, such as senescence and apoptosis. Senescence is a permanent arrest state of the cell division, which can be beneficial or detrimental for normal tissue via an inflammatory response and senescence-associated secretion phenotype. Damage to healthy cells and their microenvironment is considered as an important source of early and late complications with an increased risk of morbidity in patients after radiotherapy (RT). In addition, the benefit/risk ratio may depend on the radiation technique/dose used for cancer eradication and the irradiated volume of healthy tissues. For radiation-induced fibrosis risk, the knowledge of mechanisms and potential prevention has become a crucial point to determining radiation parameters and patients' intrinsic radiosensitivity. This review summarizes our understanding of ionizing radiation-induced senescent cell in fibrogenesis. This mechanism may provide new insights for therapeutic modalities for better risk/benefit ratios after RT in the new era of personalized treatments.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Nguyen</LastName>                    <ForeName>Hoang Quy</ForeName>                    <Initials>HQ</Initials>                    <AffiliationInfo>                        <Affiliation>University of Paris Saclay, University of Paris Est Créteil (UPEC), France, University of Medicine and Pharmacy, Ho Chi Minh City, Viet Nam; INSERM U955 Team 07, Créteil, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>To</LastName>                    <ForeName>Nhu Hanh</ForeName>                    <Initials>NH</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 07, Créteil, France; APHP, Department of Radiation Oncology and Henri Mondor Breast Cancer and, Henri Mondor University Hospital, University of Paris Est Créteil (UPEC), France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zadigue</LastName>                    <ForeName>Patricia</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 07, Créteil, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kerbrat</LastName>                    <ForeName>Stéphane</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 04, University of Paris Est Créteil (UPEC), France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>De La Taille</LastName>                    <ForeName>Alexandre</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 07, Créteil, France; APHP, Department of Urology, Henri Mondor University Hospital, University of Paris Est Créteil (UPEC), Créteil, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Le Gouvello</LastName>                    <ForeName>Sabine</ForeName>                    <Initials>S</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 04, University of Paris Est Créteil (UPEC), France; APHP, Department of Biology &amp; Pathology, Henri Mondor University Hospital, University of Paris Est Créteil (UPEC), Créteil, France.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Belkacemi</LastName>                    <ForeName>Yazid</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>INSERM U955 Team 07, Créteil, France; APHP, Department of Radiation Oncology and Henri Mondor Breast Cancer and, Henri Mondor University Hospital, University of Paris Est Créteil (UPEC), France. Electronic address: yazid.belkacemi@aphp.fr.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D016454">Review</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>06</Month>                <Day>22</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Crit Rev Oncol Hematol</MedlineTA>            <NlmUniqueID>8916049</NlmUniqueID>            <ISSNLinking>1040-8428</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>                <QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016922" MajorTopicYN="N">Cellular Senescence</DescriptorName>                <QualifierName UI="Q000528" MajorTopicYN="Y">radiation effects</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName>                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>                <QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011832" MajorTopicYN="N">Radiation Injuries</DescriptorName>                <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011839" MajorTopicYN="Y">Radiation, Ionizing</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Fibrotic tissue</Keyword>            <Keyword MajorTopicYN="N">Radiosensitivity</Keyword>            <Keyword MajorTopicYN="N">Senescence</Keyword>            <Keyword MajorTopicYN="N">Senescence-associated secretion phenotype</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>02</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>06</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>06</Month>                <Day>15</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>12</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30097231</ArticleId>            <ArticleId IdType="pii">S1040-8428(18)30085-4</ArticleId>            <ArticleId IdType="doi">10.1016/j.critrevonc.2018.06.012</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>